Cipla ready to launch coronavirus COVID-19 treatment drug Favipiravir: CSIR

Mumbai-based pharmaceutical firm Cipla is ready to launch coronavirus drug Favipiravir for the treatment of COVID-19 patients, according to an official statement released by the Council of Scientific and Industrial Research (CSIR) on Thursday (July 23, 2020). 

from Zee News :India National https://ift.tt/2CHTwTR

Comments